← Leaderboards
John C S Breitner
Johns Hopkins University
$47,172,775
Attributed
$47,172,775
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.4M · FY2005–10$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$47,172,775 · 3
By mechanism
U01$44,447,786 · 1
R01$2,724,989 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Katrin I Andreasson$26,152,030
- Eric T Oliver$986,218
- Steven Michael Claypool$8,718,131
- Zaver M Bhujwalla$35,375,851
- Xinzhong Dong$16,603,888
Others in their field
Top investigators on “Alzheimer'S Disease”
- Paul S. Aisen · Cognition Therapeutics, Inc.$200,724,578
- Randall J Bateman · Washington University$184,115,182
- Michael W Weiner · Northern California Institute Res &Educ$175,732,070
- Reisa A. Sperling · Banner Health$139,117,861
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$124,251,847
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$124,049,392
Research focus
Alzheimer'S DiseaseClinical ResearchHuman SubjectHuman Old Age (65+)Longitudinal Human StudyDrug Screening /EvaluationDisease /Disorder Prevention /ControlProstaglandin Endoperoxide SynthaseIbuprofenClinical TrialsTherapy CompliancePsychological TestsAgingDosageOutcomes ResearchCognition DisordersProstaglandin InhibitorsCombination ChemotherapyHuman Therapy EvaluationCooperative StudyDementiaProstaglandinsBrain Disorder DiagnosisAntihistamines
Grant awards (19)
Prevention of Alzheimer Dementia and Cognitive Decline$2,869,813
U01 · FY2010 · AG · contact PI
Prevention of Alzheimer Dementia and Cognitive Decline$3,115,773
U01 · FY2009 · AG · contact PI
Prostaglandins & Oxidative Damage in ADAPT Participants$294,297
R01 · FY2007 · AG · contact PI
PREVENTION OF ALZHEIMER DEMENTIA & COGNITIVE DECLINE$5,397,013
U01 · FY2006 · AG · contact PI
Prostaglandins & Oxidative Damage in ADAPT Participants$303,087
R01 · FY2006 · AG · contact PI
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$6,131,561
U01 · FY2005 · AG
Prostaglandins &Oxidative Damage in ADAPT Participants$310,381
R01 · FY2005 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$4,211,104
U01 · FY2004 · AG
Prostaglandins &Oxidative Damage in ADAPT Participants$278,881
R01 · FY2004 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$5,604,602
U01 · FY2003 · AG
Prostaglandins &Oxidative Damage in ADAPT Participants$285,381
R01 · FY2003 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$100,000
U01 · FY2003 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$5,188,211
U01 · FY2002 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$120,072
U01 · FY2002 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$6,797,842
U01 · FY2001 · AG
EPIDEMIOLOGY OF DEMENTIA IN CACHE COUNTY, UTAH$285,209
R01 · FY2001 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$124,031
U01 · FY2001 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE$4,787,764
U01 · FY2000 · AG
EPIDEMIOLOGY OF DEMENTIA IN CACHE COUNTY, UTAH$967,753
R01 · FY2000 · AG